Recruiting

Aortic Aneurysm Repair

Sponsor:

Andres Schanzer

Code:

NCT02050113

Conditions

Complex Aortic Aneurysms

Thoracoabdominal Aneurysms

Pararenal Aneurysms

Juxtarenal Aneurysms

Marfan Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Custom Made Fenestrated or Branched Stent Graft

Study Details

Brief summary:

The purpose of this study is to evaluate the safety and efficacy of custom made devices, Zenith t-Branch devices and physician modification of FDA approved off-the-shelf endovascular grafts in the treatment of patients with complex abdominal aneurysms, aortoiliac aneurysms, thoracoabdominal aneurysms and aortic arch aneurysms who (1) have anatomy not suitable for endovascular repair using grafts currently marketed in the United States,(2) are deemed unsafe to wait the required time necessary for commercial endograft manufacturing, and (3) are at high risk for open surgical repair. Amendment to the study has created a cohort open to people with connective tissue diseases such as Marfan, Ehlers-Danlos or Loey-Dietz syndromes to enroll in the trial. An additional amendment to the study allows the use of a custom made device to treat an aneurysm in the aortic arch.

Conditions

Complex Aortic Aneurysms

Thoracoabdominal Aneurysms

Pararenal Aneurysms

Juxtarenal Aneurysms

Marfan Syndrome

Study ID

NCT02050113

Start date

Mar, 2014

Status verified date

Oct, 2025

Completion date

Mar, 2030

Anticipated

Primary completion date

Mar, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • A patient may be suitable for inclusion in the study if the patient has at least one of the following:

1. Aortic or aortoiliac aneurysm with diameter ≥5.5 cm
2. Aortic or aortoiliac aneurysm with a history of growth ≥1.0 cm per year, or clinical indication for aneurysm repair based on symptoms

General Inclusion Criteria

<!-- -->

1. Cannot be treated with a currently available non-modified approved device
2. Symptomatic on presentation and unsafe to wait for the time necessary to obtain a currently available non-modified approved device
3. At least 18 years of age
4. Not pregnant or breastfeeding
5. Willing and able to comply with five years of follow-up
6. Willing and able to provide informed consent prior to enrollment
7. No systemic or local infection that may increase the risk of endovascular graft infection
8. High risk for open surgical repair based on any of the factors below:

a. Anatomic i. Previous abdominal surgery ii. Previous left-sided thoracotomy (if the proposed open repair would require dissection of the thoracic aorta) iii. Previous aortic surgery b. Physiologic i. ASA Category III or higher ii. Age >70 years iii. Previous myocardial infarction, coronary artery disease, or coronary artery stent iv. Coronary stress test with a reversible perfusion defect v. Congestive heart failure vi. COPD

Exclusion Criteria:
  • Exclusion Criteria Medical Exclusion Criteria

1. Cultural objection to receipt of blood or blood products
2. Allergy or sensitivity to stainless steel, polyester, polypropylene, solder (tin, silver), gold, or nitinol
3. Anaphylactic reaction to contrast that cannot be adequately pre-medicated
4. Uncorrectable coagulopathy
5. Unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
6. Patient has active malignancy with life expectancy of less than 2 years
7. Patient has life expectancy less than two years

Anatomical Exclusion Criteria

1. Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access
2. Proximal neck length ≤25 mm
3. Proximal neck, measured outer wall to outer wall on a sectional image (CT)

1. For use of Zenith Flex: diameter >32 mm or <18 mm
2. For use of Zenith TX2: diameter >38 mm or <24 mm (for proximal and distal neck diameter)
4. Proximal neck angulated more than 60 degrees relative to the long axis of the aneurysm
5. Proximal neck diameter change over the length of the proximal seal zone >4 mm
6. Proximal seal site with a circumferential thrombus/atheroma
7. Iliac artery diameter, measured inner wall to inner wall on a sectional image (CT) <7.0 mm at any point along access length (prior to deployment)
8. Ipsilateral iliac artery fixation site diameter, measured inner wall on a sectional image (CT) >21 mm at distal fixation site
9. Iliac artery distal fixation site <10 mm in length
10. Non-bifurcated segment of any artery to be stented < 15 mm in length
11. Artery to be stented with a maximum diameter <3 mm or >10 mm at the vessel ostium
12. Inability to maintain at least one patent hypogastric artery

Study Design

Enrollment

600 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Endovascular repair

Endovascular repair of Complex Aortic Aneurysm using a physician modified stent graft. custom made device or arch branch device.

Interventions

Custom Made Fenestrated or Branched Stent Graft

The surgeon will place a custom made graft, t-Branch device or modify commercially available stent grafts to match the anatomy of the patient being treated. Small fenestrations (holes) will be made in the stent graft so that additional stents can be inserted through the fenestration and into the blood vessels that lead to the kidneys, intestines or liver. These stents allow blood to flow freely to these organs. If the aneurysm is in the aortic arch stents may be placed in the carotid and subclavian arteries. This surgery is done through small incisions in the groin and sometimes in the upper arm.

Primary outcome measure

  • The effectiveness of physician modified endovascular grafts will be determined by evaluating the proportion of patients that achieve Treatment Success [ Time Frame: 12 months post procedure ]

Central Contacts and Locations

Central contacts

Locations

UMass Memorial Health Care - University Campus

Recruiting

Worcester, Massachusetts, United States, 01655

Contacts

Principal Investigator:

Andres Schanzer, MD

More Information

Sponsor

Andres Schanzer

Last update posted

Oct 22, 2025

Last verified

Oct, 2025

Keywords

  • Complex Aortic Aneurysms
  • Thoracoabdominal Aneurysms
  • Pararenal Aortic Aneurysms
  • Juxtarenal Renal Aneurysms
  • Endovascular Branch Graft
  • Fenestrated Stent Graft
  • Abdominal Aortic Aneurysm
  • Endovascular
  • Aortic Dissection
  • Aortic Arch Aneurysms

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Andres Schanzer on 2025-10-22.